✦ LIBER ✦

Efficacy of single-agent bortezomib vs. single-agent thalidomide in patients with relapsed or refractory multiple myeloma: a systematic comparison

✍ Scribed by H. Miles Prince; Michael Adena; Dell Kingsford Smith; Judy Hertel

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

An open-label, single-arm, phase 2 study

✍ Ravi Vij; David S. Siegel; Sundar Jagannath; Andrzej J. Jakubowiak; Alexander Ke 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 198 KB

Single-agent thalidomide for treatment o

✍ Fenk, R; Hoyer, B; Steidl, U; Kondakci, M; Graef, T; Heuk, R; Ruf, L; Strupp, C; 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 118 KB

A systematic review of phase-II trials o

✍ Axel Glasmacher; Corinna Hahn; Florian Hoffmann; Ralph Naumann; Hartmut Goldschm 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 181 KB

Clinical efficacy of a bortezomib, cyclo

✍ Yeo-Kyeoung Kim; Sang-Kyun Sohn; Jae-Hoon Lee; Deok-Hwan Yang; Joon-Ho Moon; Jae 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 175 KB

A systematic review of phase II trials o

✍ Marie Von Lilienfeld-Toal; Corinna Hahn-Ast; Kerstin Furkert; Florian Hoffmann; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 204 KB

Impact on response and survival of DNA r

✍ María Teresa Cibeira; Carlos Fernández de Larrea; Alfons Navarro; Tania Díaz; Do 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 332 KB